Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of CSL 2009 H1N1 influenza vaccine in healthy children
2014-005183-15Phase 2
- Sponsor
- CSL Limited
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of CSL H1N1 Pandemic Influenza Vaccine in influenza (2 arms), sponsored by CSL Limited. Primary endpoint: Seroconversion or significant increase in hemagglutination inhibition antibody titre.
02
Drugs
CSL H1N1 Pandemic Influenza Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-005183-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005183-15.